Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B)
Health Care · Pharmaceuticals · MX
MX$15.15
-0.13% today · -15.4% 1Y
Public summary
A free snapshot of Genomma Lab Internacional, S.A.B. de C.V., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $789.37M.
Over the last twelve months the share price has lost 15.4%, trading between 12.22 and 19.48.
Tweenvest scores Genomma Lab Internacional, S.A.B. de C.V. across four factors: quality 76/100, value 67/100, growth 40/100, dividend 92/100. Its strongest factor is dividend.
LAB B price history
Key figures
- Market cap
- $789.37M
- Revenue (TTM)
- $948.83M
- P/E
- 11.85
- EPS
- 1.57
- Dividend yield
- 5.18%
- Beta (5Y)
- -0.01
- 52-week high
- MX$19.48
- 52-week low
- MX$12.22
- Avg volume (3M)
- —
- Shares outstanding
- 973.39M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Soho Global Health TbkIDX: SOHO | $803.89M | Rp1,155.00 | 0.00% |
| Luye Pharma Group Ltd.SEHK: 2186 | $799.36M | HK$1.57 | -3.98% |
| Wuhan Keqian Biology Co.,LtdSHSE: 688526 | $797.16M | CN¥11.47 | +0.35% |
| Lexicon Pharmaceuticals, Inc.NasdaqCM: LXRX | $792.52M | $1.78 | +1.71% |
| Saudi Pharmaceutical Industries and Medical Appliances CorporationSASE: 2070 | $788.64M | SR24.86 | +0.81% |
| Jiangsu Jibeier Pharmaceutical Co., Ltd.SHSE: 688566 | $785.95M | CN¥26.09 | -0.76% |
| China Shineway Pharmaceutical Group LimitedSEHK: 2877 | $781.46M | HK$8.12 | +2.53% |
| ZhuZhou QianJin Pharmaceutical Co.,LtdSHSE: 600479 | $764.67M | CN¥10.37 | -3.62% |